151 related articles for article (PubMed ID: 8875209)
1. Influence of irradiation and androgen ablation on prostatic intraepithelial neoplasia.
Wheeler TM
Eur Urol; 1996; 30(2):261-4. PubMed ID: 8875209
[TBL] [Abstract][Full Text] [Related]
2. Persistence of high-grade prostatic intra-epithelial neoplasia under combined androgen blockade therapy.
van der Kwast TH; Labrie F; Tetu B
Hum Pathol; 1999 Dec; 30(12):1503-7. PubMed ID: 10667430
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
Alberts SR; Blute ML
Urology; 2001 Apr; 57(4 Suppl 1):188-90. PubMed ID: 11295624
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptors in untreated and treated prostatic intraepithelial neoplasia.
van der Kwast TH; Têtu B
Eur Urol; 1996; 30(2):265-8. PubMed ID: 8875210
[TBL] [Abstract][Full Text] [Related]
5. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia.
Bostwick DG; Qian J
Urology; 2001 Aug; 58(2 Suppl 1):91-3. PubMed ID: 11502458
[TBL] [Abstract][Full Text] [Related]
6. Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response.
Kang TY; Nichols P; Skinner E; Groshen S; Valin G; Ye W; Raghavan D
BJU Int; 2007 May; 99(5):1024-7. PubMed ID: 17244277
[TBL] [Abstract][Full Text] [Related]
7. Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients.
Civantos F; Marcial MA; Banks ER; Ho CK; Speights VO; Drew PA; Murphy WM; Soloway MS
Cancer; 1995 Apr; 75(7):1634-41. PubMed ID: 8826921
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
del Vecchio MT; Tripodi SA; Arcuri F; Pergola L; Hako L; Vatti R; Cintorino M
Prostate; 2000 Sep; 45(1):51-7. PubMed ID: 10960842
[TBL] [Abstract][Full Text] [Related]
9. [Total androgen blockade].
Namiki M; Mizokami A
Nihon Rinsho; 2002 Dec; 60 Suppl 11():193-8. PubMed ID: 12599570
[No Abstract] [Full Text] [Related]
10. [Significance of neoadjuvant therapy for prostate cancer].
Okada K; Hachiya T
Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):769-77. PubMed ID: 9364842
[No Abstract] [Full Text] [Related]
11. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation.
Matsushima H; Goto T; Hosaka Y; Kitamura T; Kawabe K
Cancer; 1999 Apr; 85(8):1822-7. PubMed ID: 10223578
[TBL] [Abstract][Full Text] [Related]
12. Prostatic intraepithelial neoplasia and prostate cancer.
Montironi R; Santinelli A; Mazzucchelli R
Panminerva Med; 2002 Sep; 44(3):213-20. PubMed ID: 12094135
[TBL] [Abstract][Full Text] [Related]
13. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy.
Ferguson J; Zincke H; Ellison E; Bergstrahl E; Bostwick DG
Urology; 1994 Jul; 44(1):91-5. PubMed ID: 8042266
[TBL] [Abstract][Full Text] [Related]
14. Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma.
Têtu B
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):271-83. PubMed ID: 18471785
[TBL] [Abstract][Full Text] [Related]
15. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
16. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
Alberts SR; Novotny PJ; Sloan JA; Danella J; Bostwick DG; Sebo TJ; Blute ML; Fitch TR; Levitt R; Lieberman R; Loprinzi CL
Am J Ther; 2006; 13(4):291-7. PubMed ID: 16858161
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy for precancerous lesions of the prostate.
Hull D; Bostwick DG
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):285-91. PubMed ID: 18471786
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.
Eulau SM; Tate DJ; Stamey TA; Bagshaw MA; Hancock SL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):735-40. PubMed ID: 9652832
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and prostate cancer.
Dacker R
Radiol Technol; 1997; 68(3):194-5. PubMed ID: 9008013
[No Abstract] [Full Text] [Related]
20. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]